A retrospective study to compare the 3-year antiviral efficacy of nevirapine and efavirenz in combination with D4T and 3TC in 2NN patients - 2NN Follow-up study
- Conditions
- Treatment of HIV-1 infection
- Registration Number
- EUCTR2004-000623-16-GB
- Lead Sponsor
- Boehringer Ingelheim Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 750
Inclusion Criteria
1. Participation in the initial 2NN study (protocol 1100.1288)
2. Under active follow-up at the end of the initial 2NN study (i.e. at week 48), whether or not using randomized treatment.
3. Ability and willingness to give written informed consent.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method